PDF herunterladen
Thromb Haemost 1989; 62(02): 819
DOI: 10.1055/s-0038-1646915
Letters to the Editor
Schattauer GmbH Stuttgart

Fibrin(ogen) Peptides in Early Breast Cancer

P M Mannucci
A. Bianchi Bonomi, Hemophilia and Thrombosis Center, Institute of Internal Medicine, University of Milan, Italy
,
M Cugno
A. Bianchi Bonomi, Hemophilia and Thrombosis Center, Institute of Internal Medicine, University of Milan, Italy
,
G Mameli
*   Institute of Internal Medicine, University of Cagliari, Italy
,
F Marongiu
*   Institute of Internal Medicine, University of Cagliari, Italy
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 13. April 1989

Accepted after revision 17. April 1989

Publikationsdatum:
30. Juni 2018 (online)

Auch verfügbar auf
  als PDF herunterladen  Lizenzen und Reprints
 

  • References

  • 1 McCulloch P, Douglas J, Lowe GD O, Murray G, George WD. In vivo measurements of fibrin formation and fibrinolysis in operable breast cancer. Thromb Hemostas 1989; 61: 318-321
    PubMedGoogle Scholar
  • 2 Nossel HL, Younger LR, Wilner GD, Procupez T, Canfield RE, Butler Jr VP. Radioimmunoassay of human fibrinopeptide A. Proc Natl Acad Sci USA 1971; 68: 2350-2353
    CrossrefPubMedGoogle Scholar
  • 3 Kudryk KB, Robinson D, Netre C, Hessel B, Blomback M, Blomback B. Measurement in human blood of fibrinogen/fibrin fragments containing the Bβ 14-42 sequence. Thromb Res 1982; 25: 277-291
    CrossrefPubMedGoogle Scholar
  • 4 Mannucci PM, Vaglini M, Maniezzo M, Magni E, Mari D, Cascinelli N. Hemostasis alterations are unrelated to the stage of tumor in untreated malignant melonoma and breast carcinoma. Eur J Cancer Clin Oncol 1985; 21: 681-685
    CrossrefPubMedGoogle Scholar